BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance

  December 10, 2025

   · 

  6 min read
• Press Releases

  Alligator Bioscience Comments on Henlius Receiving Regulatory Approval in China to Initiate Phase 2/3 Trials of HLX22 in HER2-Positive Breast Cancer

  December 10, 2025

   · 

  2 min read
• Press Releases

  Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses

  December 10, 2025

   · 

  14 min read
• Press Releases

  Fosun Pharma’s Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

  December 10, 2025

   · 

  2 min read
• Press Releases

  Lilly’s Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL

  December 10, 2025

   · 

  18 min read
• Press Releases

  Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual Meeting

  December 10, 2025

   · 

  10 min read
• Press Releases

  Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

  December 10, 2025

   · 

  7 min read
• Press Releases

  Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism

  December 10, 2025

   · 

  9 min read
• Press Releases

  Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026

  December 10, 2025

   · 

  7 min read
• Press Releases

  Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors

  December 10, 2025

   · 

  6 min read